Rani Therapeutics Holdings Inc (RANI)
Healthcare
Biotechnology
0.80 $
+3.5%
vs. previous close
Closing price · As of: 3. Aug 2026
Rani Therapeutics Holdings Inc (RANI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -6.5 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -12 | -14 | -12 | -9.4 | -9.0 | -8.4 | -8.7 | -8.1 | -5.8 | -5.1 | 0.3 | -6.5 | -17 | |
| 0.4 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.8 | |
| 5.1 | 5.0 | 4.5 | 3.9 | 4.1 | 4.0 | 4.0 | 3.9 | 3.3 | 2.3 | 2.2 | 2.1 | 10.0 | |
| -4.5 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1.3 | -0.9 | -3.0 | 1.2 | 0.1 | -0.7 | -1.1 | 0.0 | 1.2 | -0.3 | 6.0 | -1.0 | 6.0 | |
| 0.3 | 0.5 | 0.2 | 0.0 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 0.8 | 12 | 13 | 10 | 6.5 | 0.5 | 2.5 | 18 | 5.7 | -0.2 | -31 | -2.5 | -28 | |
| 0.0 | 0.0 | 0.4 | – | 0.0 | 0.2 | – | – | 0.0 | – | – | – | – | |
| – | – | – | – | – | -1.3 | -3.8 | -3.8 | -3.8 | -3.8 | -9.5 | 0.0 | -17 | |
| 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 7.7 | 5.6 | -3.7 | 0.2 | -1.0 | 45 | 0.0 | 44 | |
| -11 | -2.6 | 0.9 | 1.0 | -2.4 | -0.2 | -0.5 | 6.3 | 0.1 | -6.1 | 14 | -9.0 | -0.8 | |
| -13 | -15 | -13 | -9.4 | -9.1 | -8.5 | -8.7 | -8.2 | -5.8 | -5.1 | 0.3 | -6.5 | -17 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.